Latest Articles
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer - OncLive
Dostarlimab Plus Chemo Prolongs Time to First, Second Subsequent Therapy Regardless of Age in Endometrial Cancer OncLive
Published: July 11, 2025, 6:17 p.m.
BioNTech’s Promising Phase III Trial for Recurrent Endometrial Cancer - TipRanks
BioNTech’s Promising Phase III Trial for Recurrent Endometrial Cancer TipRanks
Published: July 11, 2025, 4:24 p.m.
Sussex Cancer Fund supports ground-breaking study into the impact of stress on endometrial cancer - MSN
Sussex Cancer Fund supports ground-breaking study into the impact of stress on endometrial cancer MSN
Published: July 9, 2025, 11:31 p.m.
BioNTech’s Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment - TipRanks
BioNTech’s Phase III Trial: A Potential Game-Changer in Endometrial Cancer Treatment TipRanks
Published: July 9, 2025, 4:04 p.m.
Link between endometrial cancer and stress explored in pioneering new study at University of Brighton - V2 Radio
Link between endometrial cancer and stress explored in pioneering new study at University of Brighton V2 Radio
Published: July 9, 2025, 5:05 a.m.
Sussex Cancer Fund supports ground-breaking study into the impact of stress on endometrial cancer - SussexWorld
Sussex Cancer Fund supports ground-breaking study into the impact of stress on endometrial cancer SussexWorld
Published: July 8, 2025, 1:10 p.m.
Fertility Preservation and Assisted Reproductive Strategies in Endometrial Cancer Patients with Lynch Syndrome - Frontiers
Fertility Preservation and Assisted Reproductive Strategies in Endometrial Cancer Patients with Lynch Syndrome Frontiers
Published: July 7, 2025, 1:32 p.m.
‘Life as We Knew It’ Legend Dies of Endometrial Cancer: Susan Beth Pfeffer Was 77 - suggest.com
‘Life as We Knew It’ Legend Dies of Endometrial Cancer: Susan Beth Pfeffer Was 77 suggest.com
Published: July 4, 2025, 7:49 p.m.
AstraZeneca’s New Study on Endometrial Cancer: Key Insights for Investors - TipRanks
AstraZeneca’s New Study on Endometrial Cancer: Key Insights for Investors TipRanks
Published: July 4, 2025, 4:07 p.m.
Negative Findings Reported in ENGOT-EN1 Endometrial Cancer Study Led by Kristina Lindemann - Oncodaily
Negative Findings Reported in ENGOT-EN1 Endometrial Cancer Study Led by Kristina Lindemann Oncodaily
Published: July 4, 2025, 11:44 a.m.
Link copied to clipboard!